Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming

Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE 3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease … Read more

Nvidia and Johnson & Johnson to develop new AI applications for surgery

Nvidia and Johnson & Johnson to develop new AI applications for surgery

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Johnson & Johnson. NYSE Johnson & Johnson on Monday announced it is working with Nvidia to develop and scale new artificial intelligence applications for surgery.  J&J’s MedTech unit and Nvidia plan to integrate AI within devices and platforms from pre-op … Read more

UnitedHealth Group has paid more than $2 billion to providers following cyberattack

UnitedHealth Group has paid more than  billion to providers following cyberattack

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE UnitedHealth Group Inc. headquarters stands in Minnetonka, Minnesota, U.S. Mike Bradley | Bloomberg | Getty Images UnitedHealth Group said Monday that it’s paid out more than $2 billion to help health-care providers who have been affected by the cyberattack on subsidiary Change Healthcare. “We continue to … Read more

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Jim Cramer: It’s not too late to buy this portfolio health-care stock after Friday’s selloff

Jim Cramer: It’s not too late to buy this portfolio health-care stock after Friday’s selloff

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. U.S. stocks jumped Monday as the Nasdaq and S & P 500 attempts to recover from back-to-back weekly losses. Major gains … Read more

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But … Read more

Doctors are turning medical generative AI into a booming business

Doctors are turning medical generative AI into a booming business

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Attendees at HIMSS in Orlando, Florida 2024. Courtesy of HIMSS The hottest new technology for doctors promises to bring back an age-old health-care practice: face-to-face conversations with patients. As more than 30,000 health and tech professionals gathered among the palm trees at the HIMSS conference in … Read more

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But … Read more

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that … Read more

Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit

Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC Weight Watchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial position of the company is solid and its new clinical business related to the threat … Read more

Experts hesitate on weight loss ETFs amid the obesity drug boom

Experts hesitate on weight loss ETFs amid the obesity drug boom

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist … Read more

Biden administration investigating Change Healthcare cyberattack as disruptions continue

Biden administration investigating Change Healthcare cyberattack as disruptions continue

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, the UnitedHealth Group logo is displayed on a tablet. Igor Golovniov | Sopa Images | Lightrocket | Getty Images The U.S. Department of Health and Human Services has launched an investigation into UnitedHealth Group following the cyberattack on its Change Healthcare unit … Read more

The news hitting a portfolio health-care name actually removes an overhang on the stock

The news hitting a portfolio health-care name actually removes an overhang on the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday following Tuesday’s record high close for the S & P 500 on a rebound in the … Read more

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with … Read more

Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients 

Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ … Read more

Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know

Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid.  Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a … Read more

Signos uses a glucose monitor patch and AI to help you eat healthier. Here’s what it’s like

Signos uses a glucose monitor patch and AI to help you eat healthier. Here’s what it’s like

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Ashley Capoot wearing a CGM. Ashley Capoot | CNBC As it turns out, exercise is good for you. So is sleep, and unfortunately, so are vegetables.  I’ve heard these health adages hundreds of times before, but they truly began to hit home for me this winter … Read more

Novo Nordisk CEO says experimental weight loss pill could become a best in class drug

Novo Nordisk CEO says experimental weight loss pill could become a best in class drug

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity.  The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new … Read more

Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move

Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

UnitedHealth working to restore Change Healthcare systems by mid-March, company says

UnitedHealth working to restore Change Healthcare systems by mid-March, company says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration the UnitedHealth Group logo displayed on a smartphone screen.  Sheldon Cooper | Sopa Images | Lightrocket | Getty Images UnitedHealth Group on Thursday said it expects to restore Change Healthcare’s systems by mid-March, offering a potential resolution to the ransomware attack that … Read more

Oura to sell its smart rings on Amazon as Apple, Samsung wearables competition grows

Oura to sell its smart rings on Amazon as Apple, Samsung wearables competition grows

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A closeup of Oura’s Gen3 Horizon ring and its sensors. Oura Oura will now sell its smart rings on Amazon, its latest retail expansion as the health and wellness wearable space continues to grow. Starting Thursday, Oura will have its full selection of rings and accessories … Read more

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and … Read more

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and … Read more

Salesforce announces new AI tools for doctors

Salesforce announces new AI tools for doctors

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Salesforce headquarters in San Francisco, California, US, on Wednesday, Nov. 29, 2023. David Paul Morris | Bloomberg | Getty Images Salesforce on Thursday announced new data and artificial intelligence solutions for health-care workers that could help lessen their burdensome administrative workloads.   The first tool is called … Read more

Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips

Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 5% on Thursday morning, according to LSEG data, hitting a fresh record highs after the Danish pharmaceutical giant reported positive early trial data for a new experimental weight loss drug. The company told an investor … Read more

Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20

Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023.  Chris Kleponis | Bloomberg | Getty Images President Joe Biden on Wednesday said the federal Medicare program should negotiate prices for at … Read more

Healthy Returns: What to know about CDC’s new Covid recommendations

Healthy Returns: What to know about CDC’s new Covid recommendations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia. Tami Chappell | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The Centers for Disease Control and Prevention … Read more

Dexcom announces its first-ever over-the-counter CGM Stelo has been cleared by the FDA

Dexcom announces its first-ever over-the-counter CGM Stelo has been cleared by the FDA

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the U.S. Food and … Read more

Novo Nordisk’s diabetes drug Ozempic slashed the risk of kidney disease progression in trial

Novo Nordisk’s diabetes drug Ozempic slashed the risk of kidney disease progression in trial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This picture taken on October 23, 2023, shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, eastern France.  Sebastien Bozon | Afp | Getty Images Novo Nordisk‘s blockbuster drug Ozempic cut the risk of kidney disease progression and related health complications in … Read more

Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market.  Viking is just one of several companies racing to join the growing space. Some analysts say the … Read more

Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market.  Viking is just one of several companies racing to join the growing space. Some analysts say the … Read more

Venture capital firm’s plan to buy nonprofit hospital system has Ohio community on edge

Venture capital firm’s plan to buy nonprofit hospital system has Ohio community on edge

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Dr. Marc Harrison, who’s now CEO of HATCo, speaking at the Healthy Returns conference in New York City on May 21, 2019. Astrid Stawiarz | CNBC Dr. Marc Harrison is a different kind of venture capitalist. He’s not looking for the next Mark Zuckerberg or Elon … Read more

Change Healthcare sets up new electronic prescription service, funding program as cyberattack drags

Change Healthcare sets up new electronic prescription service, funding program as cyberattack drags

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, UnitedHealth Group Inc logo seen displayed on a tablet. Igor Golovniov | Sopa Images | Lightrocket | Getty Images Change Healthcare on Friday said it’s finished setting up a new electronic prescription service, which could help provide some relief to pharmacies and … Read more

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Friday rejected AstraZeneca‘s legal challenge to Medicare’s new power … Read more

CVS and Walgreens to start selling abortion pill mifepristone this month 

CVS and Walgreens to start selling abortion pill mifepristone this month 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo Women’s Clinic in Carbondale, Illinois, April 20, 2023. Evelyn Hockstein | Reuters CVS and Walgreens will start selling the abortion pill mifepristone this month at certain pharmacy … Read more

Outages from Change Healthcare cyberattack causing financial ‘mess’ for doctors

Outages from Change Healthcare cyberattack causing financial ‘mess’ for doctors

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Small private practices and health-care providers are facing mounting financial pressures as crucial reimbursement systems remain down for the ninth day, following the cyberattack on Change Healthcare.  Change Healthcare offers tools for payment and revenue cycle management that help facilitate transactions between providers and most major … Read more

Medicaid challenges leave many Black Americans uninsured

Medicaid challenges leave many Black Americans uninsured

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Recent changes to Medicaid programs, aimed at closing a health coverage gap in the U.S., have left behind some Americans — particularly people of color. Among the non-elderly population in the U.S. — those under age 65 — insured rates rose during the Covid pandemic, with … Read more

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Ransomware group Blackcat is behind cyberattack on UnitedHealth division, company says

Ransomware group Blackcat is behind cyberattack on UnitedHealth division, company says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Change Healthcare on Thursday confirmed that ransomware group Blackcat is behind the ongoing cybersecurity attack that’s caused widespread disruptions to pharmacies and health systems across the U.S. “Our experts are working to address the matter and we are working closely with law enforcement and leading third-party … Read more

Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday. The shot’s efficacy declined compared with the levels … Read more

One down one to go — what we learned from TJX’s great quarter and hope to hear from Salesforce

One down one to go — what we learned from TJX’s great quarter and hope to hear from Salesforce

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. U.S. stocks were trending lower as investors awaited important inflation data and mulled over more quarterly earnings. January’s PCE price … Read more

The big health decisions Americans will need to make after starting new weight loss drugs

The big health decisions Americans will need to make after starting new weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan Mcdermid | Reuters For all of the promise associated with new weight loss drugs such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound in treating … Read more

The pet drugs vets are now prescribing look a lot more like human medications

The pet drugs vets are now prescribing look a lot more like human medications

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don’t need to look much further than weight loss drugs. On the human side, Novo Nordisk and Eli Lilly struggled to meet the demand for Ozempic, Wegovy, … Read more

Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs

Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Budrul Chukrut | Lightrocket | Getty Images Vaccine maker Novavax on Wednesday reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and reiterated plans to cut costs as it fights to stay afloat.  Still, Novavax narrowed its losses in the quarter from the same period … Read more

Hims & Hers soars 32% on rapid growth in mental health, weight loss and dermatology treatments

Hims & Hers soars 32% on rapid growth in mental health, weight loss and dermatology treatments

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, January 21, 2021. Carlo Allegri | Reuters Hims & Hers Health, the online provider of treatments … Read more

Healthy Returns: The newest treatment use for weight loss drugs? Liver disease

Healthy Returns: The newest treatment use for weight loss drugs? Liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Image of a healthy liver not ravaged by fatty liver disease. BSIP | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drugmakers aren’t just racing to develop drugs that treat obesity. They’re also competing to … Read more

Viking Therapeutics stock jumps 80% after positive weight loss drug trial results

Viking Therapeutics stock jumps 80% after positive weight loss drug trial results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cr | Istock | Getty Images Shares of Viking Therapeutics soared more than 80% in premarket trading Tuesday after the company’s experimental weight loss drug showed promising initial results in a mid-stage trial.  Viking Therapeutics is one of several small obesity drugmakers hoping to enter the … Read more

Huawei spinoff Honor developing a smart ring after Samsung debuts its own wearable

Huawei spinoff Honor developing a smart ring after Samsung debuts its own wearable

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE George Zhao, Chief Executive Officer of Chinese consumer electronics brand Honor, smiles as he shows the new Honor Magic 6 Pro smartphones during a presentation on the eve of the Mobile World Congress (MWC), the telecom industry’s biggest annual gathering, in Barcelona on February 25, 2024. … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

Highmark Health says it’s combining tech from Google and Epic to give doctors easier access to information

Highmark Health says it’s combining tech from Google and Epic to give doctors easier access to information

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Google Cloud CEO Thomas Kurian speaks at the Google Cloud Next event in San Francisco, April 9, 2019. Michael Short | Bloomberg | Getty Images Highmark Health announced Monday that it’s integrating technology from Google Cloud and the health-care software company Epic Systems to try to … Read more

Samsung debuts a ‘smart ring’ with health-tracking features — its first foray into the product category

Samsung debuts a ‘smart ring’ with health-tracking features — its first foray into the product category

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Samsung Galaxy Ring has various sensors to track things like heart rate. Samsung BARCELONA — Samsung’s Galaxy Ring, its latest wearable, is launching with health-tracking features including heart rate and sleep monitoring while also giving users a score of their readiness for the day, a … Read more

UnitedHealth subsidiary Change Healthcare down for a fourth day following cyberattack

UnitedHealth subsidiary Change Healthcare down for a fourth day following cyberattack

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE UnitedHealth Group Inc. headquarters stands in Minnetonka, Minnesota, U.S. Mike Bradley | Bloomberg | Getty Images Change Healthcare’s systems are down for a fourth straight day after parent company UnitedHealth Group disclosed that a suspected cybersecurity threat actor gained access to part of its information technology … Read more

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people of … Read more

Novavax to settle dispute over canceled Covid vaccine purchase agreement

Novavax to settle dispute over canceled Covid vaccine purchase agreement

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Thursday said it will settle a bitter arbitration … Read more

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product.  The results cap a rocky year for the biotech company and … Read more

Nearly all doctors feel burnout, but many are encouraged by potential of AI, survey says

Nearly all doctors feel burnout, but many are encouraged by potential of AI, survey says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Suriyapong Thongsawang | Moment | Getty Images Doctors in the U.S. are struggling to contend with burnout, staffing shortages and overwhelming administrative workloads, but many are optimistic that artificial intelligence could help to ease these problems, a new survey found.  More than 90% of physicians report … Read more

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Good afternoon! The launch of the closely watched Alzheimer’s drug Leqembi is off to a slow start. Still, demand for the treatment from Biogen and its Japanese partner Eisai is rising. That’s the update the two drugmakers gave Wall Street during their latest quarterly earnings calls earlier … Read more

AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez

AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez.  Michael, who is AbbVie’s president and … Read more

What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs

The big health decisions Americans will need to make after starting new weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag — typically between $1,000 to $1,500 a month — consumers are clamoring for drugs like Novo Nordisk‘s Wegovy and Eli … Read more

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month … Read more

Biden administration examining role of supply chain middlemen in generic drug shortages

Biden administration examining role of supply chain middlemen in generic drug shortages

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A variety of generic pills and capsules.  Nenov | Moment | Getty Images The Federal Trade Commission on Wednesday said it is examining the role that drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs, which account for … Read more

Healthy Returns: Higher medical costs are pinching insurers

Healthy Returns: Higher medical costs are pinching insurers

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A UnitedHealth Group health insurance card is seen in a wallet, Oct.14, 2019. Lucy Nicholson | Reuters Good afternoon! Health insurers are feeling the squeeze as older patients head to the doctor more than expected. CVS, which owns health insurer Aetna, on Wednesday slashed its full-year profit outlook, … Read more

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday on hotter-than-expected retail inflation data. The surprise uptick in the January consumer price index sent bond … Read more

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical … Read more

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank from a year ago, as it recorded charges related to dropping its controversial Alzheimer’s drug Aduhelm and as sales slumped in its multiple sclerosis therapies, the company’s … Read more

Wall Street changes its tune on this healthcare stock. Why we were always bullish

Wall Street changes its tune on this healthcare stock. Why we were always bullish

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer … Read more

Defense Secretary Lloyd Austin re-hospitalized for bladder issue

Defense Secretary Lloyd Austin re-hospitalized for bladder issue

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Defense Secretary Lloyd Austin takes questions during a press conference at the Pentagon in Washington, DC, on February 1, 2024.  Andrew Caballero-reynolds | Afp | Getty Images Defense Secretary Lloyd Austin was taken back to the hospital on Sunday afternoon for symptoms related to a … Read more

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments.  The dominant weight … Read more

Portfolio health care name turns its luck around thanks to management’s AI push

Portfolio health care name turns its luck around thanks to management’s AI push

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. U.S. stocks were mostly higher on Friday. The S & P 500 was on track for a fifth positive week … Read more

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of … Read more

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. Analysts at four equity research firms boosted their price targets for GE Healthcare since the maker of … Read more

CVS beats estimates, but cuts full-year profit outlook on higher medical costs

CVS beats estimates, but cuts full-year profit outlook on higher medical costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are … Read more

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July … Read more

Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes

Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Good afternoon! All eyes are on Novo Nordisk and Eli Lilly again as Wall Street looks for signs that they can address one of the biggest hurdles they faced last year. Neither company has enough supply to meet the insatiable demand for their weight loss and diabetes drugs.  One month into 2024, the … Read more

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Tuesday said its highly popular drug used for weight loss and diabetes showed promise as a treatment for fatty … Read more

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall … Read more

Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices

Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, … Read more

Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

Novo Nordisk parent to buy Catalent for .5 billion to expand Wegovy supply

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023.  Victoria Klesty | Reuters Novo Nordisk‘s parent company on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost … Read more

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 1, 2024.  Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: the fourth-quarter is now shaping up to be the … Read more

January was great for stocks — here are the top 5 performers in the portfolio

January was great for stocks — here are the top 5 performers in the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Benchmark gauges notched all-time highs as stocks charged through a busy earnings season. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth.  Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by … Read more

Ad giant Publicis paying $350 million to settle U.S. opioid crisis claims

Ad giant Publicis paying 0 million to settle U.S. opioid crisis claims

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign for Publicis Groupe SA is seen at their headquarters in Paris, France, on Sunday, July 28, 2013.  Balint Porneczi | Bloomberg | Getty Images The healthcare division of French ad giant Publicis agreed to pay $350 million to settle claims that its past marketing … Read more

Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer

Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. Source: Synchron Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company … Read more

Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021.  Andrew Kelly | Reuters Merck on Thursday reported fourth-quarter revenue and adjusted earnings that topped estimates as it … Read more

We’re trimming a health-care stock ahead of earnings — hedging our bets on business in China

We’re trimming a health-care stock ahead of earnings — hedging our bets on business in China

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re selling 95 shares of GE Healthcare at roughly $74. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,150 shares of GEHC, reducing its weighting to 2.75% from 2.97%. The small trim we’re making in GE Healthcare with the stock up slightly in an otherwise … Read more

Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments

Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Biogen headquarters in Cambridge, Massachusetts, on Tuesday, Oct. 24, 2023. Vanessa Leroy | Bloomberg | Getty Images Biogen on Wednesday said it will discontinue the sale and development of its older and highly controversial Alzheimer’s drug Aduhelm to refocus the company’s efforts to treat the … Read more

GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost

GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020.  Dado Ruvic | Reuters GlaxoSmithKline on Wednesday lifted its long-term outlook following the smash-hit launch of its new RSV vaccine. The shot targeting the severe and in some cases life-threatening … Read more

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Liselotte Sabroe | Afp | Getty Images Novo Nordisk, Europe’s largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and diabetes drug Ozempic reported … Read more

Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain

Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Vertex Pharmaceuticals on Tuesday said its experimental painkiller, which is being tested as an alternative to addictive opioids, significantly decreased post-surgery pain in late-stage … Read more

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and … Read more

Symptoms from excessive screen time cost the U.S. $73 billion a year, study finds

Symptoms from excessive screen time cost the U.S.  billion a year, study finds

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE American workers are spending too much time looking at screens. More than 104 million people in the U.S., including nearly 70% of people working office jobs, spend upwards of seven hours a day looking at screens, according to a Tuesday report from the Deloitte Economics Institute … Read more

Pfizer beats earnings estimates as declining Covid business performs better than expected

Pfizer beats earnings estimates as declining Covid business performs better than expected

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.  John Thys | … Read more

Elon Musk’s Neuralink implants brain tech in human patient for the first time

Elon Musk’s Neuralink implants brain tech in human patient for the first time

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jonathan Raa | Nurphoto | Getty Images Elon Musk‘s neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is “recovering well,” the billionaire said in a post on X, formerly known as Twitter, on Monday. The company … Read more

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now … Read more

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | … Read more

Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs

Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday … Read more

Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads

Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Tyson Foods Inc., sign at Tyson headquarters in Springdale, Ark. April L. Brown | AP Tyson Foods will become one of the first Fortune 100 companies to stop using the nation’s traditional large pharmacy benefits managers, as it looks to cut spending on high-cost drugs.    … Read more

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay 0 million

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Containers of Johnson and Johnson baby powder are displayed on a Walgreens shelf on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into whether the … Read more

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical … Read more

Gilead stock falls after disappointing lung cancer study results

Gilead stock falls after disappointing lung cancer study results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Shares of Gilead fell more than 9% on Monday after a key drug from the company did not significantly extend the lives of patients with a certain lung cancer in a late-stage trial. The results are a blow to … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Defense Secretary Austin is ‘actively involved and engaged’ while hospitalized

Defense Secretary Austin is ‘actively involved and engaged’ while hospitalized

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Secretary of Defense Lloyd J. Austin testifies before a House Armed Services Committee hearing on the conclusion of military operations in Afghanistan at the Rayburn House Office building on Capitol Hill on September 29, 2021 in Washington, DC.  Olivier Douliery | Afp | Getty Images … Read more

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to … Read more

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more

CVS to close ‘select’ pharmacies in Target stores in the coming months

CVS to close ‘select’ pharmacies in Target stores in the coming months

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A person walks by a CVS pharmacy store in Manhattan, New York, U.S., November 15, 2021. Andrew Kelly | Reuters CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle … Read more

YouTube taps hospitals to create videos to help people witnessing an overdose or heart attack

YouTube taps hospitals to create videos to help people witnessing an overdose or heart attack

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE People walk past a billboard advertisement for YouTube in Berlin, Germany, on Sept. 27, 2019. Sean Gallup | Getty Images YouTube is taking steps to fight against medical misinformation, especially when it comes to finding immediate tips on how to handle an emergency. The company on … Read more

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

J&J to acquire cancer drug developer Ambrx Biopharma for  billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing … Read more

Eli Lilly’s direct drug sales may not upend the industry alone – but others could follow suit

Eli Lilly’s direct drug sales may not upend the industry alone – but others could follow suit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access.  The company’s direct-to-consumer push announced Thursday, … Read more

Florida wins first FDA approval to import cheaper drugs from Canada

Florida wins first FDA approval to import cheaper drugs from Canada

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmacist Thomas Jensen, looks over a prescription drug at the Rock Canyon pharmacy in Provo, Utah, May 9, 2019. George Frey | Reuters The Food and Drug Administration on Friday approved Florida’s plan to import cheaper prescription drugs from Canada, a first-in-the-nation move that could reduce … Read more

Walgreens posts earnings beat but slashes quarterly dividend nearly in half

Walgreens posts earnings beat but slashes quarterly dividend nearly in half

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A man walks near a Walgreens pharmacy on March 09, 2023 in New York City.  Leonardo Munoz | Corbis News | Getty Images Walgreens reported fiscal first-quarter adjusted earnings and revenue that topped expectations on Thursday, but cut its quarterly dividend nearly in half.  The retail … Read more

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Artur Widak | Nurphoto | Getty Images Shares of Moderna jumped more than 15% on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available … Read more

Reckitt Benckiser unit recalls possibly contaminated baby formula powder, FDA says

Reckitt Benckiser unit recalls possibly contaminated baby formula powder, FDA says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Enfimil infant formula, made by Mead Johnson Nutrition Co., sits on display in a supermarket in New York, U.S. Daniel Acker | Bloomberg News | Getty Images Baby formula maker Reckitt Benckiser’s Mead Johnson Nutrition has voluntarily chosen to recall certain batches of baby formula powder … Read more

Biden administration’s Medicare drug price negotiations will face major tests in 2024

Biden administration’s Medicare drug price negotiations will face major tests in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare … Read more

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three … Read more

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces  billion deal

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Bristol Myers Squibb on Nov. 20th, 2020. NYSE Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47% on the news … Read more

Here are the big health sector themes to watch next year

Here are the big health sector themes to watch next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device … Read more

Asia’s year in review: Who had it good — and who had it bad — in 2023

Asia’s year in review: Who had it good — and who had it bad — in 2023

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we … Read more

Singapore’s latest Covid spike may be peaking, but don’t stop vaccinating, health minister says

Singapore’s latest Covid spike may be peaking, but don’t stop vaccinating, health minister says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE SINGAPORE — Singapore’s latest spike in Covid cases may be starting to peak — but the public needs to stay up to date on vaccinations, Health Minister Ong Ye Kung told CNBC on Thursday. Singapore reported 56,043 Covid cases in the week of Dec. 3 to … Read more

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond.  The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand … Read more

SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’

SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Andrew Kelly | Reuters Laura Tyler Perryman, co-founder and former CEO of the medical device startup Stimwave Technologies, was charged with allegedly defrauding investors out of $41 million … Read more

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market.  The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed … Read more

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the … Read more

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An exterior view of Moderna’s clinical manufacturing facility.  David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form … Read more

Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results

Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019.  Brian Snyder | Reuters Shares of Vertex jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a … Read more

Google is rolling out new AI models for health care. Here’s how doctors are using them

Google is rolling out new AI models for health care. Here’s how doctors are using them

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sundar Pichai, CEO of Google and Alphabet, speaks on artificial intelligence during a Bruegel think tank conference in Brussels, Belgium, on Jan. 20, 2020. Yves Herman | Reuters Google on Wednesday announced MedLM, a suite of new health-care-specific artificial intelligence models designed to help clinicians and … Read more

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company’s obesity drug Zepbound. The situation seems rather clear-cut to us: It’s no reason to sell. Eli Lilly shares on Tuesday shook off afternoon losses to … Read more

Patients regain weight after stopping Eli Lilly’s Zepbound, study says

Patients regain weight after stopping Eli Lilly’s Zepbound, study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took Eli Lilly‘s weight loss drug Zepbound regained around half of the weight they shed after stopping the newly approved treatment for a year, according to data released … Read more

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It looks like Cigna has scrapped its takeover bid for Club holding Humana , removing a dark cloud over both stocks that’s lingered since the acquisition talks surfaced nearly two weeks ago. Cigna and Humana were unable to agree on an acquisition price and other financial … Read more

Cigna shares jump on reports of abandoned Humana buyout, plans for $10 billion stock buyback

Cigna shares jump on reports of abandoned Humana buyout, plans for  billion stock buyback

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana due to disagreements on price, putting an early end to what would have been one of the largest deals of … Read more

Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs

Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In Las Vegas, Lazaro Hernandez was a flamboyant, jet-setting poker player shown in televised tournaments with stacks of colorful chips. But the casually dressed gambler spotted on security cameras with wads of cash at the casino cage was hiding a secret life. And federal investigators say … Read more

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test. Md Babul Hosen | Istock | Getty Images The U.S. Food and Drug Administration has approved the country’s first gene-editing treatment, Casgevy, for use in patients with sickle cell … Read more

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a dozen.  All the result of sickle cell disease, an inherited blood disorder where a genetic mutation causes … Read more

Biden administration asserts power to seize drug patents in move to slash high prices

Biden administration asserts power to seize drug patents in move to slash high prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, on Nov. 1, 2022. Kevin Lamarque | Reuters The Biden administration on Thursday asserted its authority to seize … Read more

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for .7 billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for roughly $8.7 billion.  Under the terms of the deal, AbbVie will pay $45 per share for Cerevel. … Read more

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy. Courtesy: Eli Lilly Eli Lilly on Tuesday said its recently approved weight loss treatment Zepbound is now available at pharmacies across the U.S., serving as an alternative to rival obesity drugs … Read more

CVS to change how it prices prescription drugs with new pharmacy reimbursement model

CVS to change how it prices prescription drugs with new pharmacy reimbursement model

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sign outside a CVS Health store in Miami, Aug. 1, 2023. Joe Raedle | Getty Images CVS Health on Tuesday said will revamp how it prices prescription drugs and scrap a complex model that typically sets how much pharmacies get reimbursed and what patients pay … Read more

Reproductive startup launches test to identify an embryo’s genetic defects before an IVF pregnancy begins

Reproductive startup launches test to identify an embryo’s genetic defects before an IVF pregnancy begins

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Noor Siddiqui, founder and CEO of Orchid, during the web summit for careers during Day 2 of the 2014 Web Summit in Dublin, Ireland, Nov. 5, 2014. Stephen McCarthy | Getty Images Reproductive technology startup Orchid on Tuesday announced a comprehensive new genetic test that may … Read more

Free ChatGPT may incorrectly answer drug questions, study says

Free ChatGPT may incorrectly answer drug questions, study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Harun Ozalp | Anadolu | Getty Images The free version of ChatGPT may provide inaccurate or incomplete responses — or no answer at all — to questions related to medications, which could potentially endanger patients who use OpenAI’s viral chatbot, a new study released Tuesday suggests. … Read more

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE BRAZIL – 2021/11/26: In this photo illustration a F. HoffmannLa Roche AG logo is seen on a screen and a hand holding a pill. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images) Sopa Images | Lightrocket | Getty Images Swiss pharmaceuticals giant Roche is set … Read more

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.  The drugmaker on Friday said it will stop developing the … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study.  The drugmaker observed high rates of adverse side effects, which … Read more

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and “potentially unsafe” … Read more

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for  billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion.  Shares of ImmunoGen jumped more than 80% … Read more

Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators

Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer urged Humana (HUM) not to pursue a merger with rival health insurer Cigna (CI), questioning the merits of a potential business combination and the likelihood of it passing U.S. antitrust review. Cigna and Humana could reach an agreement on a stock-and-cash transaction by the … Read more

Nashville’s startup scene is booming. Here’s why investors and founders are moving to ‘Music City’

Nashville’s startup scene is booming. Here’s why investors and founders are moving to ‘Music City’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE NASHVILLE, TENNESSEE – SEPTEMBER 1, 2019: Tourists visit the bars and country music venues in the Lower Broadway entertainment district in Nashville, Tennessee. (Photo by Robert Alexander/Getty Images) Robert Alexander | Archive Photos | Getty Images On a flight from Fort Lauderdale, Florida, to Nashville, Tennessee, … Read more

Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them

Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The new vaccine COMIRNATY® (Covid-19 vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, California. Irfan Khan | Los Angeles Times | Getty Images Three years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine.  Only 15.7% … Read more

Cigna shares slide after report it could merge with Humana

Cigna shares slide after report it could merge with Humana

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Cigna Group headquarters in Bloomfield, Connecticut, US, on Friday, Oct. 27, 2023.  BlooJoe Buglewicz | Bloomberg | Getty Images Shares of Cigna slid on Wednesday after a report that the company is in talks with Humana about a merger between the two health care giants. … Read more

Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Wall Street was mixed Monday after the Dow , the S & P 500 and the Nasdaq finished higher for … Read more

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters The blockbuster diabetes drug Mounjaro is more effective for weight loss … Read more

China reports no ‘unusual or novel pathogens’ after WHO seeks data on respiratory illness outbreak

China reports no ‘unusual or novel pathogens’ after WHO seeks data on respiratory illness outbreak

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Crowd gathers during China’s Lunar New Year celebrations. Nurphoto | Getty Images Chinese authorities reportedly called for vigilance Friday as a spike in respiratory illness continues to pile pressure on health care facilities in the north of the country, despite assurances that no “unusual or novel … Read more